Unknown

Dataset Information

0

Evaluation of pathogen specific urinary peptides in tick-borne illnesses.


ABSTRACT: Mass spectrometry enhanced by nanotechnology can achieve previously unattainable sensitivity for characterizing urinary pathogen-derived peptides. We utilized mass spectrometry enhanced by affinity hydrogel particles (analytical sensitivity?=?2.5 pg/mL) to study tick pathogen-specific proteins shed in the urine of patients with (1) erythema migrans rash and acute symptoms, (2) post treatment Lyme disease syndrome (PTLDS), and (3) clinical suspicion of tick-borne illnesses (TBI). Targeted pathogens were Borrelia, Babesia, Anaplasma, Rickettsia, Ehrlichia, Bartonella, Francisella, Powassan virus, tick-borne encephalitis virus, and Colorado tick fever virus. Specificity was defined by 100% amino acid sequence identity with tick-borne pathogen proteins, evolutionary taxonomic verification for related pathogens, and no identity with human or other organisms. Using a cut off of two pathogen peptides, 9/10 acute Lyme Borreliosis patients resulted positive, while we identified zero false positive in 250 controls. Two or more pathogen peptides were identified in 40% of samples from PTLDS and TBI patients (categories 2 and 3 above, n?=?59/148). Collectively, 279 distinct unique tick-borne pathogen derived peptides were identified. The number of pathogen specific peptides was directly correlated with presence or absence of symptoms reported by patients (ordinal regression pseudo-R2?=?0.392, p?=?0.010). Enhanced mass spectrometry is a new tool for studying tick-borne pathogen infections.

SUBMITTER: Magni R 

PROVIDER: S-EPMC7653918 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications


Mass spectrometry enhanced by nanotechnology can achieve previously unattainable sensitivity for characterizing urinary pathogen-derived peptides. We utilized mass spectrometry enhanced by affinity hydrogel particles (analytical sensitivity = 2.5 pg/mL) to study tick pathogen-specific proteins shed in the urine of patients with (1) erythema migrans rash and acute symptoms, (2) post treatment Lyme disease syndrome (PTLDS), and (3) clinical suspicion of tick-borne illnesses (TBI). Targeted pathoge  ...[more]

Similar Datasets

| S-EPMC7122147 | biostudies-literature
| S-EPMC4841121 | biostudies-literature
| S-EPMC3358111 | biostudies-literature
| S-EPMC8372993 | biostudies-literature
| S-EPMC3245543 | biostudies-literature
| S-EPMC6971888 | biostudies-literature
| S-EPMC8164064 | biostudies-literature
| S-EPMC7238099 | biostudies-literature
2022-11-09 | GSE217236 | GEO
| S-EPMC5438962 | biostudies-literature